188 related articles for article (PubMed ID: 19694755)
1. Cyclic opioid peptide agonists and antagonists obtained via ring-closing metathesis.
Berezowska I; Lemieux C; Chung NN; Wilkes BC; Schiller PW
Chem Biol Drug Des; 2009 Oct; 74(4):329-34. PubMed ID: 19694755
[TBL] [Abstract][Full Text] [Related]
2. Conversion of delta-, kappa- and mu-receptor selective opioid peptide agonists into delta-, kappa- and mu-selective antagonists.
Schiller PW; Weltrowska G; Nguyen TM; Lemieux C; Chung NN; Lu Y
Life Sci; 2003 Jun; 73(6):691-8. PubMed ID: 12801590
[TBL] [Abstract][Full Text] [Related]
3. Dicarba analogues of the cyclic enkephalin peptides H-Tyr-c[D-Cys-Gly-Phe-D(or L)-Cys]NH(2) retain high opioid activity.
Berezowska I; Chung NN; Lemieux C; Wilkes BC; Schiller PW
J Med Chem; 2007 Mar; 50(6):1414-7. PubMed ID: 17315860
[TBL] [Abstract][Full Text] [Related]
4. Opiate aromatic pharmacophore structure-activity relationships in CTAP analogues determined by topographical bias, two-dimensional NMR, and biological activity assays.
Bonner GG; Davis P; Stropova D; Edsall S; Yamamura HI; Porreca F; Hruby VJ
J Med Chem; 2000 Feb; 43(4):569-80. PubMed ID: 10691683
[TBL] [Abstract][Full Text] [Related]
5. Effect of aromatic amino acid substitutions in the 3-position of cyclic beta-casomorphin analogues on mu-opioid agonist/delta-opioid antagonist properties.
Schmidt R; Wilkes BC; Chung NN; Lemieux C; Schiller PW
Int J Pept Protein Res; 1996 Nov; 48(5):411-9. PubMed ID: 8956074
[TBL] [Abstract][Full Text] [Related]
6. N-methylated cyclic enkephalin analogues retain high opioid receptor binding affinity.
Weltrowska G; Berezowska I; Lemieux C; Chung NN; Wilkes BC; Schiller PW
Chem Biol Drug Des; 2010 Feb; 75(2):182-8. PubMed ID: 20028398
[TBL] [Abstract][Full Text] [Related]
7. Bifunctional μ/δ opioid peptides: variation of the type and length of the linker connecting the two components.
Ding J; Lemieux C; Chung NN; Schiller PW
Chem Biol Drug Des; 2012 Feb; 79(2):186-93. PubMed ID: 22070627
[TBL] [Abstract][Full Text] [Related]
8. Bioactivity of new mu and delta opioid peptides.
Capasso A
Med Chem; 2007 Sep; 3(5):480-7. PubMed ID: 17897075
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of stable and potent delta/mu opioid peptides: analogues of H-Tyr-c[D-Cys-Gly-Phe-D-Cys]-OH by ring-closing metathesis.
Mollica A; Guardiani G; Davis P; Ma SW; Porreca F; Lai J; Mannina L; Sobolev AP; Hruby VJ
J Med Chem; 2007 Jun; 50(13):3138-42. PubMed ID: 17539621
[TBL] [Abstract][Full Text] [Related]
10. Cyclic beta-casomorphin analogues with mixed mu agonist/delta antagonist properties: synthesis, pharmacological characterization, and conformational aspects.
Schmidt R; Vogel D; Mrestani-Klaus C; Brandt W; Neubert K; Chung NN; Lemieux C; Schiller PW
J Med Chem; 1994 Apr; 37(8):1136-44. PubMed ID: 8164255
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological activity profile of new analogues of the cyclic opioid peptide H-Tyr-c[D-Cys-Gly-Phe(pNO2)-D-Cys]-NH2 containing (S)-alpha-hydroxymethylcysteine in place of cysteine.
Witkowska R; Chung NN; Schiller PW; Zabrocki J
J Pept Sci; 2005 Jun; 11(6):361-3. PubMed ID: 15635653
[TBL] [Abstract][Full Text] [Related]
12. Cyclic dermorphin tetrapeptide analogues obtained via ring-closing metathesis.
Berezowska I; Chung NN; Lemieux C; Wilkes BC; Schiller PW
Acta Biochim Pol; 2006; 53(1):73-6. PubMed ID: 16496038
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationships of dermorphin analogues containing N-substituted amino acids in the 2-position of the peptide sequence.
Schmidt R; Kálmán A; Chung NN; Lemieux C; Horváth C; Schiller PW
Int J Pept Protein Res; 1995 Jul; 46(1):47-55. PubMed ID: 7558596
[TBL] [Abstract][Full Text] [Related]
14. N-terminal guanidinylation of TIPP (Tyr-Tic-Phe-Phe) peptides results in major changes of the opioid activity profile.
Weltrowska G; Nguyen TM; Chung NN; Wilkes BC; Schiller PW
Bioorg Med Chem Lett; 2013 Sep; 23(18):5082-5. PubMed ID: 23932788
[TBL] [Abstract][Full Text] [Related]
15. A chimeric opioid peptide with mixed mu agonist/delta antagonist properties.
Weltrowska G; Lemieux C; Chung NN; Schiller PW
J Pept Res; 2004 Feb; 63(2):63-8. PubMed ID: 15009527
[TBL] [Abstract][Full Text] [Related]
16. The TIPP opioid peptide family: development of delta antagonists, delta agonists, and mixed mu agonist/delta antagonists.
Schiller PW; Weltrowska G; Berezowska I; Nguyen TM; Wilkes BC; Lemieux C; Chung NN
Biopolymers; 1999; 51(6):411-25. PubMed ID: 10797230
[TBL] [Abstract][Full Text] [Related]
17. Conformation-activity relationships of cyclo-constrained micro/delta opioid agonists derived from the N-terminal tetrapeptide segment of dermorphin/deltorphin.
Rodziewicz-Motowidło S; Czaplewski C; Luczak S; Ciarkowski J
J Pept Sci; 2008 Aug; 14(8):898-902. PubMed ID: 18338322
[TBL] [Abstract][Full Text] [Related]
18. Novel opioid peptide derived antagonists containing (2S)-2-methyl-3-(2,6-dimethyl-4-carbamoylphenyl)propanoic acid [(2S)-Mdcp].
Ghosh A; Luo J; Liu C; Weltrowska G; Lemieux C; Chung NN; Lu Y; Schiller PW
J Med Chem; 2008 Sep; 51(18):5866-70. PubMed ID: 18800771
[TBL] [Abstract][Full Text] [Related]
19. The impact of β-azido(or 1-piperidinyl)methylamino acids in position 2 or 3 on biological activity and conformation of dermorphin analogues.
Maciejczyk M; Lasota A; Frączak O; Kosson P; Misicka A; Nowakowski M; Ejchart A; Olma A
J Pept Sci; 2016 Aug; 22(8):545-51. PubMed ID: 27443980
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of cyclic endomorphin-2 analogs.
Perlikowska R; do-Rego JC; Cravezic A; Fichna J; Wyrebska A; Toth G; Janecka A
Peptides; 2010 Feb; 31(2):339-45. PubMed ID: 19995587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
